| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,335 |
8,060 |
$484K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,030 |
3,017 |
$280K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,791 |
3,346 |
$174K |
| 99243 |
|
1,766 |
1,531 |
$172K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,594 |
1,245 |
$124K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,979 |
2,271 |
$105K |
| 99349 |
|
4,638 |
4,559 |
$79K |
| 96160 |
|
5,397 |
4,252 |
$77K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,698 |
1,349 |
$76K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,014 |
819 |
$72K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,557 |
1,257 |
$69K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,530 |
1,251 |
$68K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
787 |
641 |
$60K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,797 |
1,428 |
$50K |
| 99337 |
|
2,355 |
2,313 |
$41K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,613 |
1,329 |
$38K |
| 86696 |
|
969 |
726 |
$37K |
| 87186 |
|
1,120 |
863 |
$36K |
| 96127 |
|
2,411 |
2,101 |
$35K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
295 |
150 |
$33K |
| 99401 |
|
1,128 |
506 |
$31K |
| 87428 |
|
480 |
412 |
$30K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,417 |
699 |
$29K |
| 94760 |
|
7,117 |
5,594 |
$28K |
| 86695 |
|
988 |
740 |
$28K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
191 |
138 |
$28K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,692 |
1,431 |
$26K |
| 99348 |
|
859 |
838 |
$20K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
272 |
199 |
$19K |
| 99384 |
|
182 |
157 |
$18K |
| 87088 |
|
1,660 |
1,311 |
$18K |
| 86803 |
|
1,020 |
841 |
$17K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,684 |
1,329 |
$17K |
| 87481 |
|
272 |
133 |
$17K |
| 87503 |
|
892 |
764 |
$16K |
| 87070 |
|
2,450 |
1,961 |
$15K |
| 86704 |
|
929 |
705 |
$14K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
167 |
145 |
$14K |
| 86706 |
|
965 |
736 |
$13K |
| 99383 |
|
146 |
124 |
$13K |
| 99336 |
|
695 |
676 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,103 |
1,646 |
$12K |
| 81001 |
|
4,107 |
3,010 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
192 |
170 |
$10K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
303 |
240 |
$8K |
| 80053 |
Comprehensive metabolic panel |
657 |
543 |
$7K |
| 94010 |
|
189 |
150 |
$7K |
| 92551 |
|
429 |
334 |
$6K |
| 87510 |
|
258 |
180 |
$6K |
| 81002 |
|
2,469 |
2,178 |
$6K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
82 |
70 |
$6K |
| 99385 |
|
59 |
39 |
$6K |
| 86592 |
|
1,295 |
1,045 |
$5K |
| 87340 |
|
372 |
299 |
$5K |
| 99070 |
|
221 |
153 |
$5K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
60 |
37 |
$5K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
151 |
123 |
$5K |
| 86780 |
|
215 |
132 |
$4K |
| 81025 |
|
806 |
652 |
$3K |
| 90715 |
|
167 |
115 |
$3K |
| 90734 |
|
173 |
123 |
$2K |
| 86705 |
|
154 |
123 |
$2K |
| 99173 |
|
288 |
240 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
209 |
142 |
$2K |
| 80074 |
|
47 |
43 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
50 |
43 |
$2K |
| 86694 |
|
122 |
67 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
78 |
66 |
$1K |
| 83026 |
|
438 |
372 |
$1K |
| 85018 |
|
406 |
328 |
$934.49 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
117 |
98 |
$730.80 |
| 99344 |
|
14 |
14 |
$609.64 |
| 86709 |
|
99 |
70 |
$603.75 |
| 99327 |
|
13 |
13 |
$450.54 |
| 90649 |
|
31 |
26 |
$446.69 |
| G0180 |
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
79 |
79 |
$420.69 |
| 86707 |
|
26 |
16 |
$238.49 |
| 90710 |
|
35 |
29 |
$224.00 |
| 82962 |
|
119 |
104 |
$207.13 |
| 90713 |
|
28 |
18 |
$179.20 |
| 36415 |
Collection of venous blood by venipuncture |
23 |
12 |
$82.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
20 |
13 |
$38.34 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
96 |
70 |
$0.00 |
| 90461 |
|
60 |
43 |
$0.00 |